Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial

被引:0
作者
Jin Li
Weijian Guo
Yuxian Bai
Yanhong Deng
Lei Yang
Zhendong Chen
Haijun Zhong
Ruihua Xu
Hongming Pan
Yongqian Shu
Ying Yuan
Jianfeng Zhou
Nong Xu
Tianshu Liu
Dong Ma
Changping Wu
Ying Cheng
Jianming Xu
Donghui Chen
Wei Li
Sanyuan Sun
Zhuang Yu
Peiguo Cao
Lin Shen
Haihui Chen
Shubin Wang
Hongbing Wang
Songhua Fan
Xiaojun Guo
Ning Wang
Rubing Han
Bin Zhang
Shukui Qin
机构
[1] Tongji University East Hospital,Department of Medical Oncology
[2] Fudan University Shanghai Cancer Center,Department of Medical Oncology, Shanghai Medical College
[3] Harbin Medical University Cancer Hospital,Department of Medical Oncology
[4] The Sixth Hospital Affiliated to Sun Yat-sen University,Department of Medical Oncology
[5] Nantong Cancer Hospital,Department of Medical Oncology
[6] The Second Hospital of Anhui Medical University,Department of Medical Oncology
[7] Zhejiang Cancer Hospital,Department of Medical Oncology
[8] Sun Yat-sen University Cancer Center,Department of Medical Oncology
[9] Sir Run Run Shaw Hospital,Department of Medical Oncology
[10] Jiangsu Provincial Hospital,Department of Medical Oncology
[11] The Second Affiliated Hospital of Zhejiang University,Department of Medical Oncology
[12] Peking Union Medical College Hospital,Department of Oncology
[13] The First Affiliated Hospital Zhejiang University College of Medicine,Department of Medical Oncology
[14] Fudan University Zhongshan Hospital,Department of Medical Oncology
[15] Guangdong Provincial People’s Hospital,Department of Medical Oncology
[16] The First People’s Hospital of Changzhou,Department of Medical Oncology
[17] Jilin Province Cancer Hospital,Department of Medical Oncology
[18] The Fifth Medical Center of Chinese,Department of Medical Oncology
[19] PLA General Hospital,Department of Medical Oncology
[20] Shanghai Jiao Tong University Affiliated First People’s Hospital,Department of Medical Oncology
[21] The First Hospital of Jilin University,Department of Medical Oncology
[22] Xuzhou Central Hospital,Department of Medical Oncology
[23] The Affiliated Hospital of Medical College Qingdao University,Department of Medical Oncology, Xiangya Hospital of Central South University
[24] The Third Xiangya Hospital of Central South University,Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)
[25] Peking University Cancer Hospital & Institute,Department of Medical Oncology
[26] Liuzhou Worker’s Hospital,Department of Medical Oncology
[27] Beijing University ShenZhen Hospital,Department of Medical Oncology
[28] Beijing University,undefined
[29] The Affiliated Hospital of Xuzhou Medical College,undefined
[30] Xuzhou Medical College,undefined
[31] Hutchison MediPharma Limited,undefined
[32] Lilly China,undefined
[33] Drug Development and Medical Affairs Center,undefined
[34] Cancer Center of Jinling Hospital,undefined
来源
Advances in Therapy | 2020年 / 37卷
关键词
Adverse events of special interest; Chinese patients; FRESCO trial; Fruquintinib; Metastatic colorectal cancer; Safety profile;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4585 / 4598
页数:13
相关论文
共 88 条
  • [71] Izzedine H(undefined)undefined undefined undefined undefined-undefined
  • [72] Rixe O(undefined)undefined undefined undefined undefined-undefined
  • [73] Billemont B(undefined)undefined undefined undefined undefined-undefined
  • [74] Baumelou A(undefined)undefined undefined undefined undefined-undefined
  • [75] Deray G(undefined)undefined undefined undefined undefined-undefined
  • [76] Tang JR(undefined)undefined undefined undefined undefined-undefined
  • [77] Markham NE(undefined)undefined undefined undefined undefined-undefined
  • [78] Lin YJ(undefined)undefined undefined undefined undefined-undefined
  • [79] Lacouture ME(undefined)undefined undefined undefined undefined-undefined
  • [80] Reilly LM(undefined)undefined undefined undefined undefined-undefined